Terms: = Ovarian cancer AND ENO2, HEL-S-279, NSE AND Treatment
5 results:
1. [Comprehensive treatment of adrenal cortical carcinoma].
Deng JH; Li HZ; Ji ZG; Zhang YS; Liu GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):298-301. PubMed ID: 30996372
[TBL] [Abstract] [Full Text] [Related]
2. Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.
Bian J; Li B; Kou XJ; Wang XN; Sun XX; Ming L
Asian Pac J Cancer Prev; 2014; 15(19):8409-11. PubMed ID: 25339038
[TBL] [Abstract] [Full Text] [Related]
3. [Childhood cutaneous Abrikossoff tumor].
Lahmam Bennani Z; Boussofara L; Saidi W; Bayou F; Ghariani N; Belajouza C; Sriha B; Denguezli M; Nouira R
Arch Pediatr; 2011 Jul; 18(7):778-82. PubMed ID: 21600742
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract] [Full Text] [Related]
5. Ectopic ACTH-syndrome due to ovarian carcinoma.
Orbetzova M; Andreeva M; Zacharieva S; Ivanova R; Dashev G
Exp Clin Endocrinol Diabetes; 1997; 105(6):363-5. PubMed ID: 9439934
[TBL] [Abstract] [Full Text] [Related]
